Abstract
Impact of Fenebrutinib Treatment on MRI Outcomes and Cerebrospinal Fluid Penetrance in Multiple Sclerosis: Results from the Phase II FENopta Study (S31.004)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have